Biomarkers including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki67 have prognostic and predictive value [1,2] in early breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.